Congestive Heart Failure Treatment Devices Market Size, Share, and Analysis, By Product Type (Pacemakers, Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillators, Ventricular Assist Devices), By End User (Hospitals & Clinic, Specialized

Congestive Heart Failure Treatment Devices Market Size, Share, and Analysis, By Product Type (Pacemakers, Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillators, Ventricular Assist Devices), By End User (Hospitals & Clinic, Specialized Cardiovascular Disease Treatment Centres, Ambulatory Surgery Centres) and Regional Forecasts, 2022-2032

PRODUCT OVERVIEW

The Global Congestive Heart Failure Treatment Devices market size was USD 5.5 billion in 2021 and projected to grow from USD 6.4 billion in 2023 to USD 13 billion by 2032, exhibiting a CAGR of 8% during the forecast period.

Congestive heart failure treatment device is called as mechanical circulatory support system. There are various types of congestive heart failure treatment devices like implantable cardioverter defibrillators, cardiac resynchronization therapy devices, pacemakers, and ventricular assist devices. There are many ventricular assist devices, like left congestive heart failure treatment devices (LVADs), right congestive heart failure treatment devices (RVADs), and others which are utilized as a permanent solution in patients with minor improvement chances of cardiac muscles. The implantable cardiac defibrillator is an electronic device placed inside the body to track rhythm of heart and provide shock to the heart muscle in case of abnormal rhythm.

MARKET HIGHLIGHTS

Global Congestive Heart Failure Treatment Devices Market is expected to project a CAGR of 8% during the forecast period, 2022-2032
Global Congestive Heart Failure Treatment Devices market is expected to reach USD 13 billion at a CAGR of 8% during forecast period owing to the rising prevalence of cardiovascular disorders and increasing risk of organ failure is expected to boost the growth of the market. The increasing investments by the key players in development of congestive heart failure treatment devices is creating an opportunity for the market to grow. The increasing patient count with heart failure has created demand for ventricular assistance devices and is expected to drive the market grow.

GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET SEGMENTATION:

Pacemakers segment is expected to grow with high CAGR during forecast period

Global Congestive Heart Failure Treatment Devices Market is classified based on the Product Type into Pacemakers, Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillators, Ventricular Assist Devices. Pacemakers segment dominated the congestive heart failure treatment devices market in 2021 and is expected to continue during the forecast period due to the rising R&D activities in this industry and increasing demand for congestive heart failure treatment devices for treatment of heart failure using pacemakers. The increasing cardiac surgeries is expected to boost the growth of the market.

Hospitals & Clinic segment is expected to grow with high CAGR during 2022-2032
MARKET DYNAMICS:

Growth Drivers

• Rising Technological Advancements is Expected to Boost the Growth of the Market
• Increasing Prevalence of Cardiac Disorders will Drive the Market Growth

Restraint

• High Cost of the Treatment Devices May Restrain the Market Growth

GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICES MARKET_KEY PLAYERS COVERED:

• Boston Scientific Corporation
• Abbott
• Johnson & Johnson Services, Inc
• Mayo Foundation
• Medtronic PLC
• Biotronik SE & Co., KG
• LivaNova PLC
• Berlin Heart GmbH
• Abiomed, Inc.
• ReliantHeart Inc.
• St. Jude Medical
• Teleflex, Inc.
• Edwards Lifesciences Corporation
• Jarvik Heart, Inc.
• MicroPort Scientific Corporation
• Other Prominent Players

REGIONAL ANALYSIS
Global Congestive Heart Failure Treatment Devices Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America region dominated the market in 2021 owing to the presence of large patient population affected by cardiovascular disorders along with rising geriatric population. Asia-Pacific region is expected to dominate the market in the forecast period, owing to the high demand for CHF treatment devices. The fast-growing healthcare system in the countries of this region is expected to dominate the growth of the market in this region.

Segmentation

• Product Type

Pacemakers

Cardiac Resynchronization Therapy

Implantable Cardioverter Defibrillators

Ventricular Assist Devices

• By End User

Hospitals & Clinic

Specialized Cardiovascular Disease Treatment Centres

Ambulatory Surgery Centres

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis

*Please Note: The report will be delivered in 4-5 business days upon order confirmation*